UG Healthcare Corp. Ltd.(SG:8K7)
S$0.07-0.00 (-4.05%)
SG:8K7
UG Healthcare Corp. Ltd. financials statements
S$0.07
At close:-0.00 (-4.05%)
Want to see SG:8K7 full AI Analyst Report?
UG Healthcare Corp. Ltd. (8K7) Ratios
0 Followers
UG Healthcare Corp. Ltd. Ratios
SG:8K7's free cash flow for Q2 2024 was S$-13.84M. For the 2024 fiscal year, SG:8K7's free cash flow was decreased by S$-1.12M and operating cash flow was S$-12.72M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.82 | 2.70 | 3.83 | 4.88 | 5.74 |
| Quick Ratio | 1.61 | 1.44 | 2.23 | 3.22 | 4.08 |
| Cash Ratio | 0.56 | 0.45 | 0.73 | 1.88 | 2.70 |
| Solvency Ratio | 0.11 | -0.00 | -0.03 | -0.35 | 0.77 |
| Operating Cash Flow Ratio | 0.36 | -0.09 | -0.48 | -1.19 | 1.45 |
| Short-Term Operating Cash Flow Coverage | 0.82 | -0.20 | -1.01 | -2.43 | 8.72 |
| Net Current Asset Value | S$ 66.34M | S$ 62.18M | S$ 81.00M | S$ 111.13M | S$ 160.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.20 | 0.19 | 0.14 | 0.06 |
| Debt-to-Equity Ratio | 0.24 | 0.30 | 0.27 | 0.17 | 0.08 |
| Debt-to-Capital Ratio | 0.19 | 0.23 | 0.21 | 0.15 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.10 | 0.12 | 0.13 | 0.07 | 0.04 |
| Financial Leverage Ratio | 1.40 | 1.46 | 1.39 | 1.27 | 1.26 |
| Debt Service Coverage Ratio | 0.42 | 0.06 | -0.19 | -1.32 | 6.35 |
| Interest Coverage Ratio | 2.19 | -0.37 | -5.17 | -27.45 | 61.55 |
| Debt to Market Cap | 0.84 | 0.69 | 0.56 | 0.33 | 0.12 |
| Interest Debt Per Share | 0.07 | 0.08 | 0.07 | 0.05 | 0.03 |
| Net Debt to EBITDA | 1.15 | 9.73 | -3.99 | 1.28 | -1.54 |
| Profitability Margins | |||||
| Gross Profit Margin | 28.42% | 24.11% | 22.45% | 1.43% | 36.28% |
| EBIT Margin | 3.68% | -0.87% | -6.78% | -27.14% | 21.31% |
| EBITDA Margin | 7.57% | 1.72% | -3.42% | -23.70% | 22.95% |
| Operating Profit Margin | 3.68% | -0.57% | -5.75% | -24.84% | 21.30% |
| Pretax Profit Margin | 2.65% | -2.39% | -7.89% | -28.59% | 20.96% |
| Net Profit Margin | 1.39% | -2.63% | -5.26% | -20.50% | 15.82% |
| Continuous Operations Profit Margin | 1.76% | -3.07% | -7.56% | -27.21% | 17.11% |
| Net Income Per EBT | 52.44% | 110.29% | 66.63% | 71.70% | 75.46% |
| EBT Per EBIT | 72.04% | 421.57% | 137.13% | 115.12% | 98.42% |
| Return on Assets (ROA) | 0.87% | -1.63% | -2.67% | -9.01% | 12.77% |
| Return on Equity (ROE) | 1.22% | -2.39% | -3.71% | -11.47% | 16.07% |
| Return on Capital Employed (ROCE) | 2.90% | -0.45% | -3.52% | -12.74% | 19.75% |
| Return on Invested Capital (ROIC) | 1.72% | -0.40% | -3.10% | -11.17% | 15.68% |
| Return on Tangible Assets | 0.96% | -1.78% | -2.91% | -9.04% | 12.80% |
| Earnings Yield | 4.37% | -5.58% | -7.96% | -23.08% | 26.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.98 | 3.04 | 2.26 | 2.60 | 6.20 |
| Payables Turnover | 4.24 | 4.24 | 6.46 | 11.43 | 11.38 |
| Inventory Turnover | 1.83 | 1.70 | 1.46 | 1.83 | 2.40 |
| Fixed Asset Turnover | 2.33 | 2.34 | 2.00 | 1.69 | 3.52 |
| Asset Turnover | 0.63 | 0.62 | 0.51 | 0.44 | 0.81 |
| Working Capital Turnover Ratio | 1.72 | 1.48 | 0.98 | 0.67 | 1.48 |
| Cash Conversion Cycle | 235.73 | 249.17 | 355.70 | 308.29 | 179.07 |
| Days of Sales Outstanding | 122.62 | 120.14 | 161.74 | 140.51 | 58.87 |
| Days of Inventory Outstanding | 199.10 | 215.09 | 250.50 | 199.71 | 152.28 |
| Days of Payables Outstanding | 85.99 | 86.07 | 56.54 | 31.94 | 32.08 |
| Operating Cycle | 321.72 | 335.24 | 412.24 | 340.23 | 211.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.03 | -0.01 | -0.03 | -0.06 | 0.09 |
| Free Cash Flow Per Share | 0.02 | -0.01 | -0.03 | -0.08 | 0.05 |
| Dividend Paid and CapEx Coverage Ratio | 6.72 | -1.44 | -7.11 | -3.26 | 2.29 |
| Capital Expenditure Coverage Ratio | 6.72 | -1.44 | -7.11 | -4.88 | 2.42 |
| Operating Cash Flow Coverage Ratio | 0.43 | -0.10 | -0.42 | -1.26 | 3.00 |
| Operating Cash Flow to Sales Ratio | 0.12 | -0.03 | -0.16 | -0.39 | 0.23 |
| Free Cash Flow Yield | 31.16% | -11.92% | -27.21% | -52.51% | 23.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 22.65 | -17.87 | -12.57 | -4.33 | 3.71 |
| Price-to-Sales (P/S) Ratio | 0.32 | 0.47 | 0.66 | 0.89 | 0.59 |
| Price-to-Book (P/B) Ratio | 0.28 | 0.43 | 0.47 | 0.50 | 0.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 3.21 | -8.39 | -3.68 | -1.90 | 4.31 |
| Price-to-Operating Cash Flow Ratio | 2.73 | -14.23 | -4.19 | -2.30 | 2.53 |
| Price-to-Earnings Growth (PEG) Ratio | -0.15 | 0.48 | 0.18 | 0.03 | -0.05 |
| Enterprise Value Multiple | 5.36 | 37.23 | -23.34 | -2.47 | 1.02 |
| Enterprise Value | 61.14M | 92.07M | 91.82M | 59.21M | 54.21M |
| EV to EBITDA | 5.36 | 37.23 | -23.34 | -2.47 | 1.02 |
| EV to Sales | 0.41 | 0.64 | 0.80 | 0.59 | 0.23 |
| EV to Free Cash Flow | 4.08 | -11.35 | -4.43 | -1.26 | 1.71 |
| EV to Operating Cash Flow | 3.48 | -19.26 | -5.06 | -1.51 | 1.00 |
| Tangible Book Value Per Share | 0.24 | 0.22 | 0.23 | 0.29 | 0.38 |
| Shareholders’ Equity Per Share | 0.28 | 0.25 | 0.26 | 0.29 | 0.37 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.34 | -0.28 | 0.03 | 0.05 | 0.18 |
| Revenue Per Share | 0.24 | 0.23 | 0.18 | 0.16 | 0.38 |
| Net Income Per Share | 0.00 | -0.01 | -0.01 | -0.03 | 0.06 |
| Tax Burden | 0.52 | 1.10 | 0.67 | 0.72 | 0.75 |
| Interest Burden | 0.72 | 2.74 | 1.16 | 1.05 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.25 | 0.25 | 0.21 | 0.20 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 8.38 | 1.39 | 2.00 | 1.89 | 1.11 |
Currency in SGD

